Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P50583 (
asymmetrical
)
12,197
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Clinical and epidemiologic analyses of PPMA in Japan based on the nation-wide case survey were reported, and differences between PPMA and
ALS
were discussed. The present survey covering the years from 1984 through 1991 cited 42 PPMA cases (30 male:12 female). The absolute incidence of PPMA is estimated 0.12/10(5) of the Japanese population (about 150 cases in total), which indicates 0.5% of the polio survivors. In Japan an actual increase of patients is noticed in these 10 years, which reflects the big epidemic of polio around 1950-60. The antecedent poliomyelitis occurred at the mean age of 2.6, mostly between 1940 and 1960. Residual paralysis was generally absent or only minimal. Late muscular atrophy and weakness were noticed at age from 16 to 63 y (mean:41.5), with the mean latency of 40.1 years after polio. Both polio-affected and unaffected site of the limb were equally involved by PPMA, but the left leg tends to be predominantly involved. Neurological symptoms were summarized as an
asymmetrical
proximal muscular atrophy and flaccid motor paresis in one or two limbs with decreased tendon reflexes. Fasciculation in 45.2%, myalgia in 28.6%, and hypesthesia in 28.5% were noticed. Electromyography and muscle CT scan showed marked selective neurogenic changes. In most cases symptoms are stable or slowly progressive, with some recovery by rest or rehabilitation and deterioration by over work and/or trauma. On regarding these clinical features, PPMA is essentially different from classical
ALS
. Long-term hyperfunction of survived neurons with potential fragility by polio infection is suspected to mediate PPMA.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:[Post-poliomyelitis late progressive muscular atrophy (PPMA)--clinical analyses of Japanese cases]. 181 99
Magnetic resonance imaging (MRI) of the brain was performed in 10 patients with
amyotrophic lateral sclerosis
(
ALS
) and the findings were evaluated. Four patients had
asymmetrical
areas of increased signal intensity in the white matter. All patients showing abnormal MRI were young, had a longer clinical course, and clinically were more disabled. These MRI abnormalities were related to the pathological changes in the central white matter of patients with
ALS
and possible explanations for these findings in
ALS
are discussed.
...
PMID:MRI in patients with amyotrophic lateral sclerosis: correlation with clinical features. 195 86
Benign focal amyotrophy is a usually
asymmetrical
motor neuron disease affecting young people. Its favourable prognosis differentiates it from progressive motor neuron diseases such as the much more frequent and most severe form,
amyotrophic lateral sclerosis
(
ALS
). We report on one patient with "juvenile muscular atrophy of unilateral upper extremity" of the Hirayama type and two patients with selective amyotrophy of one calf ("wasted leg-syndrome"). In addition, we have observed three young women with selective muscle atrophy in the scapula region which has appeared stable for many years and might represent another entity of so-called benign focal amyotrophy.
...
PMID:[Benign, focal amyotrophy]. 200 95
Magnetic resonance imaging (MR) of the brain was performed in five patients with
amyotrophic lateral sclerosis
(
ALS
) and the findings were evaluated. Two patients had
asymmetrical
areas of increased signal intensity in the white matter. Such changes are not specific, but some possible explanations for these findings in
ALS
are considered.
...
PMID:Central nervous system magnetic resonance imaging findings in amyotrophic lateral sclerosis. 280 35
We report 2 patients with a treatable, immune-mediated motor polyneuropathy associated with antibodies to defined neural antigens. In these patients
asymmetrical
weakness developed in one arm and progressed over 2 to 3 years to involve the other arm, legs, and trunk. Both patients were initially diagnosed as having lower motor neuron forms of
amyotrophic lateral sclerosis
. However, repeated electrophysiological testing eventually showed multifocal conduction blocks in motor but not sensory fibers compatible with patchy selective demyelination. Serum testing by thin-layer chromatography and enzyme-linked immunosorbent assay revealed that both patients had high titers of antibody directed against GM1 and other gangliosides. Initial therapeutic trials of prednisone (100 mg daily for 4 to 6 months) and plasmapheresis were unsuccessful. Treatment with cyclophosphamide, however, was followed by marked improvement in strength in both patients.
...
PMID:A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. 284 79
Particular clinical pictures of
ALS
may occur during the course of some "benign gammapathies". We observed 12 patients (age range 57 to 74 years; 9 men-3 women) with initially benign gammapathy (9 IgG, 1 IgA, 2 IgM) associated to a clinical picture of progressive anterior horn and pyramidal tract involvement. These cases led us to recognize some particularities of gammapathy-associated
ALS
: Relative frequency of
asymmetrical
clinical manifestations, rarity of bulbar signs; Decrease of sensory nerve conduction velocities without evidence of sensory clinical symptoms (8 out 9); Increase CSF protein content including the monoclonal component, axonal degeneration and immunostaining evidence of the paraprotein fixation observed on nerve biopsies (5 out 7 cases). Association of
ALS
and gammapathy is not fortuitous as shown by epidemiology, experiments, pathology and effects of different immunological treatments as related in this study. Demonstration of infra-clinical neuropathy face to a clinical syndrome of
ALS
should prompt too careful screening for a gammapathy.
...
PMID:[Peripheral neuropathies simulating amyotrophic lateral sclerosis in gammopathies]. 323 59
The number of motor cells was significantly reduced in the C8 segment of the cervical spinal cord in all 12 cases of
amyotrophic lateral sclerosis
(
ALS
), in the C6 and/or C8 segments in 1 case of adult onset spinal muscular atrophy, 2 cases of Werdnig-Hoffmann (W-H) disease, 3 of 4 cases of chronic polyneuropathy and in 1 case of poliomyelitis and 1 of ossification of the posterior longitudinal ligament in the cervical spine (OPLL). The numbers of motor cells were normal in the C6 or C8 segment in 6 cases of muscular dystrophy, except in one case of congenital muscular dystrophy, who showed reduced numbers of the motor cells. Examination of the distribution of motor cells per 500 micrometers thickness in serial sections revealed that reduction in numbers of the motor cells was diffuse and symmetrical in half the cases of
ALS
and W-H disease and in the cases of chronic polyneuropathy and congenital dystrophy; diffuse but
asymmetrical
in the other
ALS
and W-H disease cases and in a case of adult spinal muscular atrophy, and localized and
asymmetrical
in the cases of poliomyelitis and OPLL. In muscular dystrophy the distribution of motor cells showed segmental variations similar to controls.
...
PMID:Morphometric quantification of the cervical limb motor cells in various neuromuscular diseases. 742 Jan 21
Pure motor neuropathy syndromes resemble
amyotrophic lateral sclerosis
variants with no upper motor neuron signs. Their identification is important, as, in contrast to
amyotrophic lateral sclerosis
, they are often immune mediated and treatable. Typically the immune-mediated motor neuropathy syndromes are distal and
asymmetrical
and progress slowly. The clinical features may help alert the clinician to the diagnosis, but other ancillary evidence such as abnormalities on electrophysiological testing and the presence of serum autoantibodies to neural antigens are helpful in making the diagnosis more secure. Electrophysiological abnormalities include not only motor conduction block but also other evidence of a demyelinative process such as prolonged distal latencies or F-wave abnormalities. High-titer anti-GM1 antibodies occur frequently but more specific patterns of reactivity may be especially helpful. Treatment of these motor neuropathy syndromes includes cyclophosphamide, which we use in combination with plasma exchange, and in some patients, human immune globulin. Clinical responses to therapy may occur within the first 2 to 4 months in patients with motor neuropathy syndromes with demyelinative features, but only become obvious 6 months or later after starting treatment in patients with predominantly axonal disorders.
...
PMID:Chronic motor neuropathies: diagnosis, therapy, and pathogenesis. 896 16
MRI was performed in 32 patients with motor neurone disease (26 men and 6 women, aged 40-77 years) and in a control group of 21 subjects. Of the patients studied, 19 had definite and 11 probable
amyotrophic lateral sclerosis
(
ALS
) and two had progressive bulbar palsy. In 10 patients there were
asymmetrical
bilateral foci of increased signal intensity on proton-density and T2-weighted images, confined to the white matter. Two patients had only cortical frontal atrophy and slightly increased ventricular size, whereas 20 had normal MRI. The focal lesions were not confined to corticospinal tracts, but were also observed in subcortical frontal areas. While the lesions along the corticospinal tracts correspond to pyramidal tract degeneration, the subcortical foci correlate with degeneration of the frontal bundles and indicate generalised involvement of the central nervous system.
...
PMID:Subcortical frontal lesions on MRI in patients with motor neurone disease. 963 70
We report on the clinical characteristics of
amyotrophic lateral sclerosis
(
ALS
) in Fortaleza (Northeastern Brazil). For this, we analyzed retrospectively (from 1980 to 1999) 78 cases of
ALS
from the Service of Neurology of the University Hospital of Fortaleza diagnosed clinically and laboratorially (EMG, muscle biopsy, myelography, blood biochemistry, muscle enzymes and cranio-cervical X-ray). The results showed that they were mostly sporadic
ALS
(76/78), and they were divided into definite (n = 36), probable (n = 20), possible (n = 15) and suspected (n = 7), according to the level of diagnostic certainty. They were also subdivided into juvenile (n = 17), early-onset adult (n = 18), age-specific (n = 39) and late-onset (n = 4) groups. Clinically, they presented as initials symptoms, principally,
asymmetrical
(30/78) and symmetrical (24/78) weakness of extremities, besides bulbar signs, fasciculations, and atrophy. Curiously, pain as first symptom occurred in an expressive fashion (17/78). The predominant initial anatomic site, in this series, was the spinal cord, and mainly affecting the arms. As to the symptom accrual from region to region, this occurs more quickly in contiguous areas, and fasciculations are predominant when bulbar region was associated.
...
PMID:Amyotrophic lateral sclerosis. Clinical analysis of 78 cases from Fortaleza (northeastern Brazil). 1075 10
1
2
3
4
Next >>